Hostname: page-component-f554764f5-fnl2l Total loading time: 0 Render date: 2025-04-20T10:51:48.393Z Has data issue: false hasContentIssue false

Pharmacist-Implemented Self-Management Module in Multiple Sclerosis Patients: A Randomized Controlled Trial

Published online by Cambridge University Press:  13 November 2024

Cansu Goncuoglu*
Affiliation:
Selçuk University, Faculty of Pharmacy, Department of Clinical Pharmacy, Konya, Turkiye
Pinar Acar Ozen
Affiliation:
Hacettepe University, Faculty of Medicine, Department of Neurology, Ankara, Turkiye
Merve Kasikci
Affiliation:
Hacettepe University, Faculty of Medicine, Department of Biostatistics, Ankara, Turkiye
Asli Tuncer
Affiliation:
Hacettepe University, Faculty of Medicine, Department of Neurology, Ankara, Turkiye
Aygin Bayraktar Ekincioglu
Affiliation:
Hacettepe University, Faculty of Pharmacy, Department of Clinical Pharmacy, Ankara, Turkiye
*
Corresponding author: Cansu Goncuoglu; Email: [email protected]

Abstract

Background:

Self-management practices can contribute to the lives of patients with multiple sclerosis. The aim of this study is to improve patients’ self-management abilities through a multidisciplinary developed module.

Methods:

This prospective, randomized controlled trial was conducted between January 2020 and November 2021 at a university hospital in Ankara, Turkiye. The self-management module was implemented by a clinical pharmacist with the aim of enhancing self-management capabilities through an educational approach, with a focus on medication adherence, management of drug-related problems, follow-ups and self-directed activities. The intervention group completed the self-management module, while the control group received usual outpatient care. To evaluate the impact of the module, the Multiple Sclerosis Self-Management Revised scale was administered to the patients. Interviews were conducted at 4-month intervals.

Results:

Study (n = 102) and control group (n = 98) patients were followed up for 8 months, and the median duration of intervention was 11 minutes. The mean (± SD) self-management scores of the study group increased from 68.9 (± 9.3) to 79.0 (± 9.4) at the end of the interviews, and this increase was found to be significant compared to the control group (p < 0.001). The self-management module has been shown to improve self-management, medication adherence, perception of care and patient engagement in treatment (p < 0.001).

Conclusions:

This single-center randomized controlled trial suggests that a pharmacist-implemented self-management module increased patient engagement and medication adherence. The self-management interventions could be tailored to groups that tend to have lower self-management abilities, such as older individuals, and those who have lower educational attainment, health engagement or medication adherence.

Résumé

RésuméContexte :

Les pratiques de prise en charge personnelle peuvent faciliter la vie des personnes atteintes de sclérose en plaques (SP). L’étude visait à améliorer les capacités de prise en charge personnelle de la maladie par les patientes et les patients eux-mêmes à l’aide d’un module pluridisciplinaire.

Méthode :

Il s’agit d’un essai comparatif, prospectif, à répartition aléatoire, qui a été réalisé entre janvier 2020 et novembre 2021, dans un hôpital universitaire, à Ankara, en Türkiye. Le module de prise en charge personnelle a été mis en œuvre par un pharmacien clinicien dans le but d’améliorer les capacités des patients à s’occuper de leur maladie par une approche éducative, notamment en ce qui concerne l’observance médicamenteuse, la prise en charge des effets indésirables des médicaments, le suivi et les initiatives personnelles. Le groupe expérimental a franchi toutes les étapes du module de prise en charge personnelle, tandis que le groupe témoin a reçu les soins usuels en consultation externe. L’équipe de recherche a demandé aux participants et aux participantes de répondre aux questions de l’échelle Multiple Sclerosis Self-Management Revised scale afin d’évaluer l’incidence du module sur leur vie. Les entretiens de suivi ont été effectués tous les quatre mois.

Résultats :

Le groupe expérimental (n = 102) et le groupe témoin (n = 98) ont fait l’objet de suivi durant une période de 8 mois et la durée médiane des interventions était de 11 minutes. La moyenne des résultats (± écart-type) relatifs à la prise en charge personnelle dans le groupe expérimental est passée de 68,9 (± 9,3) à 79,0 (± 9,4) à la fin des entretiens, écart considéré comme une augmentation significative comparativement au groupe témoin (p < 0,001). Le module a permis d’améliorer la prise en charge personnelle, l’observance médicamenteuse, la perception des soins et le rôle actif des malades dans leur traitement (p < 0,001).

Conclusion :

Les résultats de cet essai comparatif, unicentrique et à répartition aléatoire donnent à penser que le module de prise en charge personnelle mis en œuvre par un pharmacien a eu pour effet d’améliorer la participation des malades et l’observance médicamenteuse. Il serait possible d’adapter les interventions de prise en charge personnelle aux difficultés que rencontrent certains groupes, par exemple les personnes âgées, celles qui ont un niveau moindre de scolarité, qui sont peu motivées à jouer un rôle actif dans leur santé ou qui ont des manquements à l’observance médicamenteuse.

Type
Original Article
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of Canadian Neurological Sciences Federation

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Multiple Sclerosis International Federation. 3rd Edition, Atlas of MS, (2020, accessed 23/03/2022). https://www.msif.org/wp-content/uploads/2020/10/Atlas-3rd-Edition-Epidemiology-report-EN-updated-30-9-20.pdf (2020.Google Scholar
Toosy, A, Ciccarelli, O, Thompson, A. Symptomatic treatment and management of multiple sclerosis. Handb Clin Neurol. 2014;122:513562. DOI: 10.1016/b978-0-444-52001-2.00023-6.Google Scholar
Allegrante, JP, Wells, MT, Peterson, JC. Interventions to support behavioral self-management of chronic diseases. Annu Rev Public Health. 2019;40:127146. DOI: 10.1146/annurev-publhealth-040218-044008.Google Scholar
Hauser, SL, Cree, BAC. Treatment of multiple sclerosis: a review. Am J Med. 2020;133:13801390.e1382. DOI: 10.1016/j.amjmed.2020.05.049.Google Scholar
National Clinical Guideline Centre (UK). National Institute for Health and Care Excellence: Clinical Guidelines. Multiple Sclerosis: Management of Multiple Sclerosis in Primary and Secondary Care. London: National Institute for Health and Care Excellence (UK); October 2014.Google Scholar
Liddy, C, Blazkho, V, Mill, K. Challenges of self-management when living with multiple chronic conditions: systematic review of the qualitative literature. Can Fam Physician. 2014;60:11231133.Google Scholar
Ballester, M, Orrego, C, Heijmans, M, et al. Comparing the effectiveness and cost-effectiveness of self-management interventions in four high-priority chronic conditions in Europe (COMPAR-EU): a research protocol. BMJ Open. 2020;10:e034680. DOI: 10.1136/bmjopen-2019-034680.Google Scholar
Malcomson, KS, Lowe-Strong, AS, Dunwoody, L. What can we learn from the personal insights of individuals living and coping with multiple sclerosis? Disabil Rehabil. 2008;30:662674. DOI: 10.1080/09638280701400730.Google Scholar
Ghahari, S, Forwell, SJ, Suto, MJ, et al. Multiple sclerosis self-management model: personal and contextual requirements for successful self-management. Patient Educ Couns. 2019;102:10131020. DOI: 10.1016/j.pec.2018.12.028.Google Scholar
Lorig, KR, Holman, H. Self-management education: history, definition, outcomes, and mechanisms. Ann Behav Med. 2003;26:17. DOI: 10.1207/s15324796abm2601_01.Google Scholar
Wilski, M, Tasiemski, T. Illness perception, treatment beliefs, self-esteem, and self-efficacy as correlates of self-management in multiple sclerosis. Acta Neurol Scand. 2016;133:338345. DOI: 10.1111/ane.12465.Google Scholar
Bishop, M, Frain, MP, Rumrill, PD, et al. The relationship of self-management and disease modifying therapy use to employment status among adults with multiple sclerosis. J Vocat Rehabil. 2009;31:119127. DOI: 10.3233/JVR-2009-480.Google Scholar
Koopman, W, Schweitzer, A. The journey to multiple sclerosis: a qualitative study. J Neurosci Nurs. 1999;31:1726.Google Scholar
Hanson, RL, Habibi, M, Khamo, N, et al. Integrated clinical and specialty pharmacy practice model for management of patients with multiple sclerosis. Am J Health Syst Pharm. 2014;71:463469. DOI: 10.2146/ajhp130495.Google Scholar
Schulz, KF, Altman, DG, Moher, D, et al. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Bmc Med. 2010;8:18. DOI: 10.1186/1741-7015-8-18.Google Scholar
Osterberg, L, Blaschke, T. Adherence to medication. N Engl J Med. 2005;353:487497. DOI: 10.1056/NEJMra050100.Google Scholar
Bishop, M, Frain, MP. The multiple sclerosis self-management scale: revision and psychometric analysis. Rehabil Psychol. 2011;56:150159. DOI: 10.1037/a0023679.Google Scholar
Graffigna, G, Barello, S, Bonanomi, A, et al. Measuring patient engagement: development and psychometric properties of the patient health engagement (PHE) scale. Front Psychol. 2015;6:274 DOI: 10.3389/fpsyg.2015.00274.Google Scholar
Glasgow, RE, Wagner, EH, Schaefer, J, et al. Development and validation of the patient assessment of chronic illness care (PACIC). Med Care. 2005;43:436444. DOI: 10.1097/01.mlr.0000160375.47920.8c.Google Scholar
Abraham, C, Michie, S. A taxonomy of behavior change techniques used in interventions. Health Psychol. 2008;27:379387. DOI: 10.1037/0278-6133.27.3.379.Google Scholar
Plow, MA, Finlayson, M, Rezac, M. A scoping review of self-management interventions for adults with multiple sclerosis. Pm r. 2011;3:251262. DOI: 10.1016/j.pmrj.2010.11.011.Google Scholar
Basger, BJ, Moles, RJ, Chen, TF. Development of an aggregated system for classifying causes of drug-related problems. Ann Pharmacother. 2015;49:405418. DOI: 10.1177/1060028014568008.Google Scholar
Erbay, Ö., Usta Yeşilbalkan, Ö., Yüceyar, N, et al. Validity and reliability study of the Turkish version of multiple sclerosis self-management scale. J Neurosci Nurs. 2020;52:122127. DOI: 10.1097/jnn.0000000000000507.Google Scholar
Polat, C, Tülek, Z, Kürtüncü, M, et al. Validity and reliability of the Turkish version of the monitoring my multiple sclerosis scale. Noro Psikiyatr Ars. 2017;54:131136. DOI: 10.5152/npa.2016.12694.Google Scholar
İncirkuş, K, Nahcivan, N. Kronik hastalık bakımını değerlendirme ölçeği-hasta formu’nun Türkçe versiyonunun geçerlik ve güvenirliği. DEUHFED. 2011;4:102109.Google Scholar
Usta, D, Korkmaz, F, Akyar, I, et al. Patient health engagement scale: validity and reliability for turkish patients with chronic diseases. Cukurova Med J. 2019;44:10551063. DOI: 10.17826/cumj.482420.Google Scholar
Gulick, EE, Namey, M, Halper, J. Monitoring my multiple sclerosis: a patient-administered health-assessment scale. Int J MS Care. 2011;13:137145. DOI: 10.7224/1537-2073-13.3.137.Google Scholar
Maher, JM, Markey, JC, Ebert-May, D. The other half of the story: effect size analysis in quantitative research. CBE Life Sci Educ. 2013;12:345351.Google Scholar
Cree, BAC, Hartung, H-P, Barnett, M. New drugs for multiple sclerosis: new treatment algorithms. Curr Opin Neurol. 2022;35:262270. DOI: 10.1097/wco.0000000000001063.Google Scholar
Fraser, R, Ehde, D, Amtmann, D, et al. Self-management for people with multiple sclerosis. Int J MS Care. 2013;15:99106. DOI: 10.7224/1537-2073.2012-044.Google Scholar
Ehde, DM, Arewasikporn, A, Alschuler, KN, et al. Moderators of treatment outcomes after telehealth self-management and education in adults with multiple sclerosis: a secondary analysis of a randomized controlled trial. Arch Phys Med Rehabil. 2018;99:12651272. DOI: 10.1016/j.apmr.2017.12.012.Google Scholar
Kidd, T, Carey, N, Mold, F, et al. A systematic review of the effectiveness of self-management interventions in people with multiple sclerosis at improving depression, anxiety and quality of life. PLoS One. 2017;12:e0185931. DOI: 10.1371/journal.pone.0185931.Google Scholar
Wilski, M, Tasiemski, T, Kocur, P. Demographic, socioeconomic and clinical correlates of self-management in multiple sclerosis. Disabil Rehabil. 2015;37:19701975. DOI: 10.3109/09638288.2014.993435.Google Scholar
Desmedt, M, Vertriest, S, Petrovic, M, et al. Seen through the patients’ eyes: quality of chronic illness care. Fam Pract. 2018;35:446451. DOI: 10.1093/fampra/cmx123.Google Scholar
Barello, S, Palamenghi, L, Graffigna, G. The mediating role of the patient health engagement model on the relationship between patient perceived autonomy supportive healthcare climate and health literacy skills. Int J Environ Res Public Health. 2020;17:1741. DOI: 10.3390/ijerph17051741.Google Scholar
Arafah, AM, Bouchard, V, Mayo, NE. Enrolling and keeping participants in multiple sclerosis self-management interventions: a systematic review and meta-analysis. Clin Rehabil. 2017;31:809823. DOI: 10.1177/0269215516658338.Google Scholar
Mah, HC, Muthupalaniappen, L, Chong, WW. Perceived involvement and preferences in shared decision-making among patients with hypertension. Fam Pract. 2016;33:296301. DOI: 10.1093/fampra/cmw012.Google Scholar
Basci, D, Tulek, Z. Assessment of cognitive function and its predictors in patients with multiple sclerosis: a case-control study. Neurol Sci. 2023;44:10091016. DOI: 10.1007/s10072-022-06524-8.Google Scholar
Efendi, H, Ünal, A, Akçalı, A, et al. The effect of cognitive performance on self-management behavior of multiple sclerosis patients. Mult Scler Relat Disord. 2022;63:103880. DOI: 10.1016/j.msard.2022.103880.Google Scholar
Yang, C, Lee, DTF, Wang, X, et al. Effects of a nurse-led medication self-management intervention on medication adherence and health outcomes in older people with multimorbidity: a randomised controlled trial. Int J Nurs Stud. 2022;134:104314. DOI: 10.1016/j.ijnurstu.2022.104314.Google Scholar
Hessler, D, Fisher, L, Dickinson, M, et al. The impact of enhancing self-management support for diabetes in community health centers through patient engagement and relationship building: a primary care pragmatic cluster-randomized trial. Transl Behav Med. 2022;12:909918. DOI: 10.1093/tbm/ibac046.Google Scholar
Hosseinzadeh, H, Verma, I, Gopaldasani, V. Patient activation and Type 2 diabetes mellitus self-management: a systematic review and meta-analysis. Aust J Prim Health. 2020;26:431442. DOI: 10.1071/py19204.Google Scholar
Howell, D, Pond, GR, Bryant-Lukosius, D, et al. Feasibility and effectiveness of self-management education and coaching on patient activation for managing cancer treatment toxicities. J Natl Compr Canc Netw. 2023;21:247256.e248. DOI: 10.6004/jnccn.2022.7095.Google Scholar
Glasgow, RE, Whitesides, H, Nelson, CC, et al. Use of the patient assessment of chronic illness care (PACIC) with diabetic patients: relationship to patient characteristics, receipt of care, and self-management. Diabetes Care. 2005;28:26552661. DOI: 10.2337/diacare.28.11.2655.Google Scholar
Lim, MT, Lim, YMF, Teh, XR, et al. Patient experience on self-management support among primary care patients with diabetes and hypertension. Int J Qual Health Care. 2019;31:3743. DOI: 10.1093/intqhc/mzy252.Google Scholar
Soelberg Sorensen, P, Giovannoni, G, Montalban, X, et al. The multiple sclerosis care unit. Mult Scler. 2019;25:627636. DOI: 10.1177/1352458518807082.Google Scholar
Warsi, A, Wang, PS, LaValley, MP, et al. Self-management education programs in chronic disease: a systematic review and methodological critique of the literature. Arch Intern Med. 2004;164:16411649. DOI: 10.1001/archinte.164.15.1641.Google Scholar
Lorig, KR, Sobel, DS, Ritter, PL, et al. Effect of a self-management program on patients with chronic disease. Eff Clin Pract. 2001;4:256262.Google Scholar
Knaster, ES, Yorkston, KM, Johnson, K, et al. Perspectives on self-management in multiple sclerosis: a focus group study. Int J MS Care. 2011;13:146152. DOI: 10.7224/1537-2073-13.3.146.Google Scholar
Hemmatpoor, B, Gholami, A, Parnian, S, et al. The effect of life skills training on the self-management of patients with multiple sclerosis. J Med Life. 2018;11:387393. DOI: 10.25122/jml-2018-0044.Google Scholar
Marrie, RA, Kosowan, L, Cutter, G, et al. Disparities in telehealth care in multiple sclerosis. Neurol Clin Pract. 2022;12:223233. DOI: 10.1212/cpj.0000000000001167.Google Scholar
Tan, H, Cai, Q, Agarwal, S, et al. Impact of adherence to disease-modifying therapies on clinical and economic outcomes among patients with multiple sclerosis. Adv Ther. 2011;28:5161. DOI: 10.1007/s12325-010-0093-7.Google Scholar
Tremlett, H, Van der Mei, I, Pittas, F, et al. Adherence to the immunomodulatory drugs for multiple sclerosis: contrasting factors affect stopping drug and missing doses. Pharmacoepidemiol Drug Saf. 2008;17:565576. DOI: 10.1002/pds.1593.Google Scholar
Supplementary material: File

Goncuoglu et al. supplementary material

Goncuoglu et al. supplementary material
Download Goncuoglu et al. supplementary material(File)
File 32.5 KB